UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma

Annals of oncology, 2011-07, Vol.22 (7), p.1622-1627

2011

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker

Clinical cancer research, 2004-12, Vol.10 (23), p.7852-7859

2004

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide (LEN) in patients with transformed lymphoma: Results from a large international phase II study (NHL-003)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8037-8037

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of lenalidomide oral monotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma: Final results of NHL-001

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8560-8560

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of lenalidomide oral monotherapy in patients with relapsed or refractory mantle-cell lymphoma: Results from an international study (NHL-003)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8569-8569

2009

Link zum Volltext

Verfügbarkeit prüfen

Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury

Canadian journal of physiology and pharmacology, 1982-11, Vol.60 (11), p.1415

1982

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Injection of DTI-015 into Recurrent Malignant Gliomas: Phase I/II Trial

Neoplasia (New York, N.Y.), 2003-01, Vol.5 (1), p.9-16

2003

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results from a phase I/II study of the combination of lenalidomide and DTIC in patients with metastatic malignant melanoma previously untreated with systemic chemotherapy

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.8533-8533

2007

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.8066-8066

2007

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide oral monotherapy in relapsed/refractory small lymphocytic non-Hodgkin’s lymphoma

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8573-8573

2008

Link zum Volltext

Verfügbarkeit prüfen

International study of lenalidomide in relapsed/refractory aggressive non-Hodgkin’s lymphoma

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8509-8509

2008

Link zum Volltext

Verfügbarkeit prüfen

Safety of lenalidomide monotherapy in patients with relapsed or refractory aggressive non-Hodgkin’s lymphom

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8603-8603

2008

Link zum Volltext

Verfügbarkeit prüfen

DTI-015 Produces Cures in T9 Gliosarcoma

Neoplasia (New York, N.Y.), 2003-01, Vol.5 (1), p.17-22

2003

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory aggressive non-Hodgkin lymphoma

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.8052-8052

2007

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor : a pharmacokinetic study

Journal of neuro-oncology, 2005-07, Vol.73 (3), p.225-238

2005

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results from two phase II studies of lenalidomide monotherapy in relapsed/refractory non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.17569-17569

2006

Link zum Volltext

Verfügbarkeit prüfen

Loss of Ascorbic Acid from Injured Feline Spinal Cord

Journal of neurochemistry, 1983-01, Vol.41 (4), p.1072-1076

1983

Link zum Volltext

Verfügbarkeit prüfen

Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015

Journal of neuro-oncology, 2003-05, Vol.62 (3), p.251-258

2003

Link zum Volltext

Verfügbarkeit prüfen

Interaction of DNA and liposomes as a model for membrane-mediated DNA damage

Nature (London), 1977-05, Vol.267 (5606), p.78-79

1977

Link zum Volltext

Verfügbarkeit prüfen

Effect of difluoromethylornithine on the antiglioma therapeutic efficacy of intra-arterial BCNU

Journal of neurosurgery, 1986-11, Vol.65 (5), p.671

1986

Link zum Volltext

Verfügbarkeit prüfen

Reductive metabolism of ascorbic acid in the central nervous system

Brain research, 1985-04, Vol.333 (1), p.161-164

1985

Link zum Volltext

Verfügbarkeit prüfen

Direct quenching of adriamycin radicals by coenzyme Q10 and tetrazolium salts

Biochemical pharmacology, 1983-04, Vol.32 (8), p.1441-1444

1983

Link zum Volltext

Verfügbarkeit prüfen

In vivo metabolism of radiolabeled putrescine in gliomas: implications for positron emission tomography of brain tumors

Neurosurgery, 1988-10, Vol.23 (4), p.464-469

1988

Link zum Volltext

Verfügbarkeit prüfen

The Development of Secondary Pathology with free Radical Reactions as a Threshold Mechanism

Journal of the American College of Toxicology, 1983-01, Vol.2 (3), p.173-184

1983

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Metabolism of Radiolabeled Putrescine in Gliomas: Implications for Positron Emission Tomography of Brain Tumors

Neurosurgery, 1988-10, Vol.23 (4), p.464-469

1988

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma

Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker

Lenalidomide (LEN) in patients with transformed lymphoma: Results from a large international phase II study (NHL-003)

Efficacy of lenalidomide oral monotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma: Final results of NHL-001

Efficacy and safety of lenalidomide oral monotherapy in patients with relapsed or refractory mantle-cell lymphoma: Results from an international study (NHL-003)

Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury

Stereotactic Injection of DTI-015 into Recurrent Malignant Gliomas: Phase I/II Trial

Preliminary results from a phase I/II study of the combination of lenalidomide and DTIC in patients with metastatic malignant melanoma previously untreated with systemic chemotherapy

Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma

Lenalidomide oral monotherapy in relapsed/refractory small lymphocytic non-Hodgkin’s lymphoma

International study of lenalidomide in relapsed/refractory aggressive non-Hodgkin’s lymphoma

Safety of lenalidomide monotherapy in patients with relapsed or refractory aggressive non-Hodgkin’s lymphom

DTI-015 Produces Cures in T9 Gliosarcoma

Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory aggressive non-Hodgkin lymphoma

Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor : a pharmacokinetic study

Preliminary results from two phase II studies of lenalidomide monotherapy in relapsed/refractory non-Hodgkin’s Lymphoma

Loss of Ascorbic Acid from Injured Feline Spinal Cord

Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015

Interaction of DNA and liposomes as a model for membrane-mediated DNA damage

Effect of difluoromethylornithine on the antiglioma therapeutic efficacy of intra-arterial BCNU

Reductive metabolism of ascorbic acid in the central nervous system

Direct quenching of adriamycin radicals by coenzyme Q10 and tetrazolium salts

In vivo metabolism of radiolabeled putrescine in gliomas: implications for positron emission tomography of brain tumors

The Development of Secondary Pathology with free Radical Reactions as a Threshold Mechanism

In Vivo Metabolism of Radiolabeled Putrescine in Gliomas: Implications for Positron Emission Tomography of Brain Tumors

Suchergebnisse filtern